Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials-Reference-Cited by-同舟云学术

Surrogate End Points for Overall Survival in Metastatic, Locally Advanced, or Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of 24 Randomized Controlled Trials

Published:2017-04-10 Issue:8 Volume:24 Page:2371-2378
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Makris Eleftherios A.,MacBarb Regina,Harvey Danielle J.,Poultsides George A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-5826-2/fulltext.html

Reference57 articles.

1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22:151–85.

2. He P, Lai TL, Su Z. Design of clinical trials with failure-time endpoints and interim analyses: an update after fifteen years. Contemp Clin Trials. 2015;45:103–112.

3. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol. 2003;21:1404–11.

4. Schilsky RL. End points in cancer clinical trials and the drug approval process. Clin Cancer Res. 2002;8:935–8.

5. National Cancer Institute Dictionary of Cancer Terms. 2016. https://www.cancer.gov/publications/dictionaries/cancer-terms . Accessed 2 Jan 2016.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer;Journal of Cancer Research and Clinical Oncology;2024-01-26

2. Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreatic cancer clinical trial;Statistical Methods in Medical Research;2023-03-15

3. Surrogate Endpoints in Oncology: Overview of Systematic Reviews and Their Use for Health Decision Making in Mexico;Value in Health Regional Issues;2021-12

4. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework;Health Technology Assessment;2021-12

5. Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling;Cancer Cell International;2021-08-19